Celltrion
068270.KS
#651
Rank
A$54.51 B
Marketcap
A$239.60
Share price
-0.93%
Change (1 day)
21.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): A$4.79

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$4.92. In 2025 the company made an earnings per share (EPS) of A$4.67 an increase over its 2024 EPS that were of A$1.77.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$4.792.56%
2025A$4.67163.66%
2024A$1.77-53.73%
2023A$3.83-2.08%
2022A$3.91-11.72%
2021A$4.432.03%
2020A$4.3482.8%
2019A$2.3718.31%
2018A$2.01-36.33%
2017A$3.15161.25%
2016A$1.212.86%
2015A$1.1717.84%
2014A$1.005.87%
2013A$0.94-70.85%
2012A$3.23134.09%
2011A$1.3843.59%
2010A$0.9674.49%
2009A$0.55317.8%
2008A$0.13-71.7%
2007A$0.47